T Miyata Selected Research

T Miyata Research Topics

Disease

5	Stroke (Strokes) 08/2009 - 08/2001
5	Atherosclerosis 11/2007 - 03/2000
4	Neoplasms (Cancer) 01/2020 - 11/2001
4	Inflammation (Inflammations) 01/2020 - 07/2001
4	Type 2 Diabetes Mellitus (MODY) 11/2016 - 11/2013
4	Chronic Kidney Failure (Chronic Renal Failure) 09/2014 - 08/2000
4	Abdominal Aortic Aneurysm 03/2012 - 01/2000
4	Ischemia 09/2007 - 06/2001
4	Pathologic Constriction (Stenosis) 12/2006 - 01/2000
4	Venous Thrombosis (Deep-Vein Thrombosis) 09/2006 - 04/2000
4	Uremia 01/2002 - 08/2000
3	Hypoxia (Hypoxemia) 01/2017 - 06/2000
3	Insulin Resistance 10/2015 - 07/2000
3	Infections 09/2014 - 08/2000
3	Thrombotic Thrombocytopenic Purpura 07/2013 - 07/2011
3	Vascular Diseases (Vascular Disease) 01/2012 - 07/2001
3	Proteinuria 12/2007 - 05/2000
3	Protein C Deficiency 08/2001 - 01/2000
2	Thrombosis (Thrombus) 01/2017 - 07/2007
2	Aneurysm (Aneurysms) 10/2014 - 01/2000
2	Necrosis 09/2014 - 04/2004
2	Diabetes Mellitus 11/2013 - 12/2001
2	Atherosclerotic Plaque (Atheroma) 03/2012 - 07/2001
2	Thromboangiitis Obliterans (Buerger's Disease) 04/2011 - 10/2000
2	Renal Insufficiency (Renal Failure) 11/2010 - 10/2000
2	Essential Hypertension 05/2010 - 11/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2010 - 07/2003
2	Hemorrhage 04/2010 - 06/2001
2	Peripheral Arterial Disease 04/2010 - 07/2009
2	Obesity 12/2007 - 07/2000
2	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2001 - 01/2001
2	Leukemia 09/2001 - 03/2000
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2001 - 01/2000
2	Cerebral Infarction 08/2001 - 01/2000
2	Amyloidosis 01/2001 - 08/2000
2	Bile Duct Neoplasms (Bile Duct Cancer) 04/2000 - 04/2000
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 04/2000 - 01/2000
1	Ischemic Stroke 01/2022
1	HIV Infections (HIV Infection) 01/2021
1	Heart Failure 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Body Weight (Weight, Body) 11/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 09/2006 - 04/2000
5	LipidsIBA 01/2016 - 05/2000
5	Protein CIBA 09/2006 - 01/2000
4	Advanced Glycation End ProductsIBA 12/2001 - 10/2000
3	Blood Glucose (Blood Sugar)IBA 11/2016 - 11/2013
3	thiamine triphosphorate (TTP)IBA 07/2013 - 07/2011
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2009 - 06/2001
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2015
2	Hemoglobins (Hemoglobin)IBA 11/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 07/2000
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 10/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2014 - 09/2000
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2013 - 06/2000
2	MicellesIBA 01/2012 - 07/2007
2	Contrast MediaIBA 10/2011 - 11/2010
2	Insulin (Novolin)FDA Link 05/2010 - 12/2007
2	AnticoagulantsIBA 03/2010 - 09/2006
2	Hyaluronic Acid (Hyaluronan)IBA 06/2007 - 08/2003
2	PlasminogenIBA 11/2003 - 04/2000
2	CarbohydratesIBA 01/2002 - 08/2000
2	CreatinineIBA 11/2001 - 05/2000
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2000 - 04/2000
2	4- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamideIBA 07/2000 - 05/2000
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 07/2000 - 05/2000
2	HomocysteineIBA 06/2000 - 04/2000
1	AlbuminsIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	BucladesineIBA 01/2017
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2017
1	mirdametinibIBA 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2016
1	Guanosine Triphosphate (GTP)IBA 11/2016
1	SodiumIBA 11/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2016
1	Alanine Transaminase (SGPT)IBA 11/2016
1	SymportersIBA 11/2016
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 11/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2016

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2000
4	Endovascular Aneurysm Repair 03/2012 - 01/2000
4	Carotid Endarterectomy 09/2007 - 12/2004
4	Stents 12/2006 - 01/2000
3	Renal Dialysis (Hemodialysis) 01/2021 - 07/2001
3	Glycemic Control 01/2016 - 12/2007
3	Limb Salvage 09/2014 - 01/2003
2	Surgical Amputation (Amputations) 01/2021 - 09/2014
2	Blood Transfusion (Blood Transfusions) 01/2019 - 07/2011
2	Catheters 08/2000 - 01/2000
1	Thrombectomy 01/2022
1	Liver Transplantation 01/2021
1	Lasers (Laser) 01/2017
1	Endurance Training 01/2017
1	Intravenous Administration 01/2017